RDNT - RadNet: Qualified Growth Route Still Undervalued
2024-06-04 20:03:25 ET
Summary
- RadNet, Inc. shares continue to show strength, having compounded by 184% since 2022.
- Q1 FY 2024 earnings showed growth in the Digital Health segment and increased MRI, CT, and PET/CT volumes.
- Management has increased its outlook on full-year revenues and projects $1.67-$1.7 billion in revenue for the year.
Investment Summary
Shares of RadNet, Inc. ( RDNT ) continue to offer extensive appeal to unlock risk capital for quality-oriented investors. Since my last publication on the company in July last year, the equity line has curled up more than 88%, and the position has compounded by 184% cumulatively since I first bought it for our portfolios in 2022.
RadNet 12-month share price evolution
Seeking Alpha
RNDT's management is deploying capital at a rapid pace to grow the profit-producing capital on its books. There are no inventories in this business, and the cost of revenues is high, given that human capital is a major factor....
RadNet: Qualified Growth Route, Still Undervalued